The host response to infection appears to be regulated by specific patterns of local cytokine production. In the mouse, resistance to many pathogens including Leishmania is associated with a THl cytokine profile, IL-2 and IFN-,y; whereas susceptibility to infection is associated with production of TH2 cytokines, IL4, IL-5, and IL-10. To determine the cytokine patterns of the local immune response to Leishmania infection in humans, we used the polymerase chain reaction to compare cytokine mRNAs in biopsy specimens of American cutaneous leishmaniasis. In localized cutaneous leishmaniasis and the Montenegro delayed-type hypersensitivity reaction, type 1 cytokine mRNAs such as IL-2, IFN-y, and lymphotoxin were relatively predominant. In the chronic and destructive mucocutaneous form of leishmaniasis, there was a mixture of type 1 and type 2 cytokines, with a striking abundance of IL4 mRNA in lesions. These results suggest that clinical course of infection with Leishmania braziliensis in man is associated with specific local patterns of cytokine production. (J. Clin. Invest. 1993.
1. Abbreviations used in this paper: ACL, American cutaneous leishmaniasis; LCL, localized cutaneous leishmaniasis; MCL, mucocutaneous leishmaniasis.
Although T cells are believed to contribute to the pathogenesis of the different forms of American cutaneous leishmaniasis (ACL), it has not been determined whether there are any differences in the T cell response in LCL vs. MCL patients. Resolution of LCL lesions is associated with acquisition of a specific cell-mediated immune response (1) (2) (3) . For example, the Montenegro skin test, a 48-h delayed-type hypersensitivity reaction to intradermal challenge with Leishmania antigen, is positive in LCL patients (4, 5) . However, the test is even more positive in MCL patients. Peripheral blood T cell responses to Leishmania antigen are of significant magnitude in both LCL and MCL patients. Furthermore, immunopathologic examination of skin lesions from both LCL and MCL patients showed remarkably similar T cell patterns (6) .
The present study was undertaken to determine the range of cytokines produced in human lesions ofACL. To perform a comprehensive analysis of multiple cytokines expressed in these small biopsy specimens, we exploited the power of PCR using cytokine-specific oligonucleotide primers.
Methods
Patients. Biopsy specimens were obtained from 10 patients with LCL and 10 patients with MCL. Although some patients with MCL had cutaneous lesions, all biopsy specimens studied were taken from mucosal lesions. All MCL specimens were from the nasal mucosa and were of uniform size and histology. The diagnosis was established by means of clinical, epidemiologic, parasitologic (imprints, cultivation either in Schneider's or NNN make and histologic exam), and/or immunologic parameters (Montenegro skin test and indirect immunofluorescence analysis) criteria. Montenegro skin tests were performed by injecting 0.1 ml of leishmanin (40 ,g nitrogen/ml) intradermally, and measuring induration after 48 h. Induration < 5 mm in diameter was considered to be a positive response. Development of cutaneous lesions required an average of 3 mo and all were ulcerated. All cases were from an endemic area of Rio de Janeiro, Brazil, where only L. braziliensis has been isolated (7). In addition, four Montenegro skin tests were studied from patients with cutaneous lesions. The clinical data of the patients studied is included in Table I .
Biopsy specimens. Incisional skin biopsy specimens from the border of the ulcer of LCL lesions, incisional biopsy specimens from MCL lesions, and punch biopsies from positive Montenegro skin tests were obtained, embedded in OCT medium (Ames Co., Elkhart, IN) and rapidly frozen in liquid nitrogen. The tissues were stored at -700C until sectioning.
RNA isolation and cDNA synthesis. Total RNA was isolated from biopsy specimens by the method of Chomczynski and Sacchi (8) . To facilitate the rapid lysis of the cells isolated from tissue, 40 x 5 Mm cryostate sections were added to 4 M guanidinium isothiocyanate buffer. The samples were treated with DNase 1 (Promega Corp., Madison, WI) for 30 min at 37°C. RNase inhibitor (Boehringer Mannheim Corp., Indianapolis, IN) was present during all enzymatic manipulations of RNA. cDNA was synthesized from oligo-dT primed RNA by incubation at 42°C with AMV reverse transcriptase (Bethesda Research Laboratories, Gaithersburg, MD) and 0.5 mM dNTPs for 1 h. Radioactive hybridization of PCR product. To verify cytokine mRNAs, PCR products were transferred to Hybond-N nylon membranes (Amersham Corp., Arlington Heights, IL) and probed with a labeled oligonucleotide complementary to sequences internal to the sequences recognized by the PCR amplification primers. Blots were hybridized for 4 h, washed for 5 min with 2x SSC and 0.1% SDS, followed by 0.2x SSC and 0.5% SDS at ambient temperature, and exposed to X-ray film. Quantification ofPCR product. PCR products were quantified using an AMBIS radioanalytic imaging system (Automated Microbiology Systems Inc., San Diego, CA). Gels were scanned and the amount of radioactivity hybridized to specific PCR products was determined.
The intensity of individual bands was expressed as "relative cpm" with the most intense band assigned the value of 100 and the other bands expressed as a percentage. Statistical differences between groups were assessed by the Student t test on actual cpm.
Validity ofPCR. PCR analysis of 10-fold serially diluted plasmids containing IL-2, IL-4, IFN-y, IL-6, IL-10, and TNF-a cDNAs indicated by visualization by ethidium bromide staining that our PCR procedure was sensitive to the order of 102 to I03 copies for each cytokine ( 10). Furthermore, the intensity of the PCR product increased according to the number of copies of starting plasmid to at least I09 copies. These PCR products were transferred to nylon membrane, probed, and quantified by radioanalytic imaging. There was a log-linear correlation between the number of starting copies and the quantity of PCR products throughout the range investigated. These results indicate that our PCR conditions provide meaningful comparison ofthe small amounts of cytokine mRNAs present in lesions.
A number of controls were employed to ensure accurate comparisons of the different samples studied. Upon PCR amplification of serial 1O-fold dilutions of sample cDNAs a concomitant decrease in the PCR product was observed. Similarly, varying the number of PCR cycles did not change the relative differences between samples. These studies indicate that our PCR conditions are not within the plateau phase of amplification. Mixing of cDNAs from different patients did not inhibit or augment PCR amplification, indicating that cDNAs do not directly alter PCR efficiency. Each experiment included a positive control (PMA + ionomycin-treated PBMC) and a negative control (eithersample RNA that had not been reverse transcribed or buffer alone). The latter control did not yield PCR product confirming the absence of extraneous cDNA or PCR product contaminating the samples. In addition, we routinely used extensive precautions to avoid PCR artifact including assembling reactions in laminar flow hoods, use of aliquoted reagents, pipettes dedicated for assembling PCR reactions, and aerosolresistant tips (Continental Lab Products, La Jolla, CA).
Results
Cytokine patterns in leishmaniasis lesions determined by PCR.
Several cytokines are produced by a variety of cell types including lymphocytes, macrophages, and keratinocytes. To ascertain whether the pattern of these cytokines in lesions could be correlated with the clinical expressions of ACL, we examined cytokine expression in ACL lesions by PCR. Initially, cDNAs were normalized to the fl-actin PCR product to standardize the amount of PCR total cellular mRNA in each PCR reaction. We compared the cytokine patterns for LCL and MCL lesions to that of Montenegro reactions, the standard measure of delayed-type hypersensitivity in this disease (Fig. 1) . IL-11 and TNF-a mRNAs were strongly expressed in virtually all biopsy specimens studied, with little discernible difference between the various disease states. IL-6 and GM-CSF mRNAs were strongly expressed in approximately one half of the specimens, again with little difference between each disease state. We conclude from these experiments that this set of cytokines, largely produced by macrophages, is equally expressed in LCL and MCL lesions, as well as Montenegro reactions.
To compare lymphokine mRNAs in leishmaniasis lesions, cDNAs from different samples and disease states were normalized to the CD36 PCR product as a control for quantity of T cell mRNA template for amplification. The amount of cDNA used was identical to that according to,B-actin normalization in 90% of specimens. Examination of electrophoresed PCR product indicated distinct lymphokine patterns in the different disease states (Fig. 2) . IL-2 (although weakly expressed), IFN--y, and lymphotoxin mRNAs were again present in LCL, MCL, GM-CSF Figure 1 . PCR amplification of cytokine mRNAs associated with a variety of cell types. RNA was isolated from lesions, and cDNA was synthesized and normalized to the amount ofB-actin PCR product. PCR was performed using specific paired oligonucleotide primers. The results are shown for a representative sample of all patients studied. MTN, Montenegro reaction.
and Montenegro reactions. In marked contrast, however, the levels of IL-4, IL-5, and IL-1O mRNAs were, in general, higher in MCL lesions. IL-4 PCR product was prominent in three of six MCL specimens, with moderate PCR product detected in an additional two of six biopsies. These results were confirmed by Southern blot analysis of the PCR products. In contrast, significant IL-4 PCR product could be derived from only one of six LCL specimens. These results indicate that the pattern of lymphokine mRNAs in MCL lesions was distinct from LCL and Montenegro reactions. The cytokine mRNA levels measured by PCR were much greater than that found in normal skin (Uyemura et al., manuscript submitted for publication).
Quantification of lymphokine mRNAs in leishmaniasis lesions. To more accurately compare the levels of lymphokine mRNAs in lesions, PCR products were transferred to nylon membrane, hybridized with a 32P-labeled oligonucleotide primer complementary to a sequence internal to the PCR amplification primers, and scanned according to ,3 emission. The levels of PCR products for IL-2, IFN-'y, and lymphotoxin were similar for all the forms of ACL studied (Fig. 3, top left ). In each instance the level of PCR product was greater, although not significantly, in LCL compared to MCL lesions. The most striking finding of the present study was that the levels of IL-4 mRNA as determined by PCR were elevated in MCL lesions compared to LCL lesions (P < 0.001 ) and Montenegro reactions (Fig. 3, top left and bottom) . These results indicate a potentially important role for IL-4 in the pathogenesis of MCL. Titration of plasmid containing IL-4 cDNA (10) indicated that the three-to fourfold differences in relative cpm represent -1,000-fold differences in sample cDNA. The IL-5 and IL-10 PCR products appeared to be greater in MCL than LCL lesions but these differences did not achieve statistical significance. mRNAs. The key finding ofthe present study was that mRNAs for IL-4, and to a lesser extent IL-5 and IL-10, were most abundant in MCL lesions. Other cytokines studied, such as TNF-a, IL-I,, IL-6, GM-CSF, IL-2, IFN-'y, and lymphotoxin appear equally abundant in LCL and MCL lesions as well as Montenegro reactions. Analysis of a larger group of patients should more fully define the cytokine pattern associated with each form of the disease.
Specific lymphokine patterns have recently been found to be associated with the response to infection in humans. In normal individuals and individuals with resistance to mycobacterial infection, the "type 1" lymphokine pattern, typified by IL-2 and IFN-y, is selected for by peripheral blood T cells in response to mycobacteria ( 17, 18) . Type 1 lymphokines and lymphokine mRNAs predominate in the lesions of patients with limited infection to Mycobacterium leprae, termed tuberculoid leprosy (9, 19, 20) . In contrast, "type 2" lymphokine mRNAs, such as IL-4, IL-5, and IL-10, predominate in the lesions of lepromatous leprosy patients, individuals with susceptibility to widespread infection (9) . Type 2 lymphokines also appear to be associated with Loa loa infection in humans (21, 22) . Distinct functional populations of human T cells conforming to these specific cytokine patterns have also been elucidated. CD4-positive clones from tuberculoid leprosy lesions produce IFN-'y and CD8-positive T suppressor clones from lepromatous leprosy lesions are responsible for IL-4 production (23) . In the present study, LCL lesions as well as the Montenegro DTH reaction appear to typify the type 1 response, characteristic of limited and/or self-healing lesions. The type 1 pattern was also found in the Montenegro reaction,
Discussion
The identification of the cytokines that are involved in resistance to infection and/or contribute to tissue injury has been advanced by the study of disease in murine models. These investigations have identified two immunoregulatory subsets of murine CD4-positive cells that influence the outcome of infection ( 1). T cells that produce IL-2 and IFN-T, termed TH 1 cells ( 11), augment cell-mediated immune responses by activating macrophages to kill or inhibit the growth of the pathogen. The TH 1 response results in mild or self-curing disease. In contrast, T cells producing IL4, IL-5, and IL-1O, termed TH2 cells, augment humoral responses and inhibit some cell-mediated immune responses, which results in disseminated infection. These patterns have been shown to correlate with the outcome ofLeishmania infection in murine models, with resistance versus susceptibility regulated by THl and TH2 populations, respectively (12) (13) (14) (15) (16) .
It is not at all clear whether similar patterns of cytokine production correlate with the human manifestations of Leishmania infection. In our previous study of ACL lesions in Brazil, we found that: (a) CD4-positive T memory cells were the predominant phenotype in both LCL and MCL lesions as well has a major role in the regulation of Ig production (30) , it has recently been found to have a down-regulatory effect on cell-mediated immune responses. IL-4 stimulates murine TH2 cell proliferation (31), blocks IL-2-dependent proliferation of human T cells by down-regulation of IL-2 receptor expression (32), abrogates both the IFN-,y mediated activation of monocytes to kill Leishmania parasites (33) , and blocks macrophage nitric oxide generation necessary for killing intracellular parasites (34) . The cross regulatory effects of IL-4 and IFN-y in the host response to infection have been best demonstrated in the murine leishmaniasis model. In L. major infection, healing in C57/BL mice is accompanied by an increase in IFN-'y production by Leishmania antigen-specific cells and in the susceptible BALB/c mice, there is an increase in IL-4 production (12-16). Injection of BALB/c mice with neutralizing anti-IL-4 antibody results in attenuation of disease in 100% and cure in 85% of the animals ( 15).
It is not implausible that IL-4 may play a key role in the pathogenesis of MCL lesions, perhaps by partially suppressing the antileishmanial effects of IFN-,y. Some, but not all of the parasites would be killed, resulting in the chronicity and tissue injury which characterize this form of leishmaniasis. Apparently, the local IL-4 production is insufficient to block induction of the type 1 lymphokines. The elevated Ig levels in MCL patients provide evidence for production ofthe type 2 lymphokines (5, 35) . Interestingly, parallel studies ofpatients in Venezuela indicate that the highest levels of IL-4 mRNA occur in patients with diffuse cutaneous leishmaniasis (Dittmar et al., manuscript in preparation). Thus IL-4 may have a key role in suppression ofcell-mediated responses to infection in humans, including leishmaniasis and leprosy. Alternatively, IL-4 may have an immunopathogenic role, contributing to an autoimmune process in MCL by facilitating antibody production (36) . The present data provide evidence that the pathogenesis of human leishmaniasis is associated with distinct cytokine patterns and provides a framework for studying local cytokine production in parasitic disease.
